What Happens if You Take Too Much Benzonatate?

Taking too much benzonatate can trigger seizures, cardiac arrest, and death, sometimes within minutes of swallowing the pills. Unlike many medications where an overdose builds gradually and gives warning signs over hours, benzonatate overdose can escalate from normal alertness to life-threatening collapse with alarming speed. The drug’s chemistry explains the danger: it is structurally related to potent local anesthetics, and at high doses it blocks sodium channels throughout the nervous system and heart rather than just in the lungs where it is supposed to work.

How Benzonatate Works at Normal Doses

Benzonatate is a non-narcotic cough suppressant that was first approved in 1958. It quiets coughing by numbing the stretch receptors in the lungs and airways, dampening the signal that tells your brain to cough. It does this by blocking voltage-gated sodium channels in those receptors in a way that is reversible and dose-dependent.¹ Chemically, it is closely related to amino ester local anesthetics like tetracaine and procaine, the same class of drugs dentists use to numb your mouth.² At prescribed doses (usually 100 or 200 mg up to three times daily), the drug stays mostly local to the respiratory tract, and side effects tend to be mild: some drowsiness, dizziness, or a numb feeling in the mouth if a capsule is chewed or dissolved rather than swallowed whole.

The problem is that benzonatate has what researchers describe as a narrow therapeutic margin, meaning the gap between a dose that works and a dose that is dangerous is uncomfortably small.² With many common medications, you could accidentally double your dose and feel unwell but not face immediate danger. Benzonatate does not offer that cushion.

What an Overdose Looks Like

When someone takes too much benzonatate, the sodium channel blockade that normally stays confined to the lung stretch receptors spreads to the brain and heart. The progression tends to follow a recognizable pattern: restlessness and tremors appear first, which can rapidly escalate into full tonic-clonic (grand mal) seizures. After the seizure activity, the central nervous system may crash into deep depression, leading to coma, respiratory failure, and cardiac arrest.³

An FDA review of benzonatate overdose reports spanning four decades found that the most common serious effects were seizures, cardiac arrest, coma, brain swelling or oxygen deprivation to the brain, stopped breathing, rapid heart rate, and respiratory arrest. In some patients, these symptoms appeared within 15 minutes of swallowing the drug.⁴ That speed is part of what makes benzonatate overdose so dangerous. Fifteen minutes is barely enough time to recognize something is wrong and call for help, let alone get to a hospital.

The cardiac effects deserve particular attention. Because benzonatate blocks sodium channels in heart muscle, it can disrupt the electrical conduction that keeps the heart beating in rhythm. In one published case, a 14-year-old girl was found in cardiac arrest within minutes of last being seen well after a benzonatate overdose. She was in asystole (a flatline rhythm) when paramedics arrived, and even after her heart was restarted, her electrocardiogram showed a dangerously widened QRS interval, a hallmark of sodium channel poisoning in the heart.⁵

Why It Can Kill So Quickly

Most people are familiar with the idea that drug overdoses build over hours as the body absorbs and metabolizes the substance. Benzonatate breaks that expectation. The drug’s anesthetic properties mean that once it reaches a toxic concentration in the bloodstream, it simultaneously disrupts the electrical signaling in the brain (causing seizures and then coma) and the heart (causing rhythm disturbances and arrest). These are not sequential problems the body works through one at a time. They hit together, and either one alone can be fatal.

Another factor is the capsule itself. Benzonatate comes in soft gelatin capsules (sometimes called “perles”) that contain the drug in liquid form. If a capsule is chewed, bitten, or dissolved in the mouth instead of swallowed whole, the concentrated liquid inside can cause immediate and severe numbing of the mouth and throat. This local anesthesia of the airway can increase the risk of choking and aspiration, where food, saliva, or liquid enters the lungs because the swallowing reflex has been numbed away.⁶ Even a single chewed capsule at a normal dose can cause this throat-numbing effect, which is why the label warns against chewing.

Children Are at Especially High Risk

The danger of benzonatate is magnified in young children for several reasons. First, their smaller body weight means a single adult capsule represents a much larger relative dose. Case reports suggest that even one or two capsules can be fatal in a small child. The FDA issued a specific Drug Safety Communication warning that accidental benzonatate ingestion in children younger than 10 carries an increased risk of death and updated the drug’s labeling to reflect this.⁷

Second, the capsules themselves are a hazard. They are small, round, shiny, and soft, and to a toddler they look like candy. Children who find loose capsules in a bag or on a counter may pop several into their mouths at once, and are likely to chew them rather than swallow them whole, releasing the concentrated liquid directly into the throat and speeding up absorption.² This combination of higher relative dose, faster absorption from chewing, and a smaller body to absorb the drug creates a worst-case scenario. If you have benzonatate in the house and young children are present, keeping it in a child-resistant container and well out of reach is not optional safety advice; it is the difference between a non-event and a potential fatality.

Teenagers also appear in the case literature. A published case report describes a teenager who developed coma, seizures, and severe metabolic acidosis after a benzonatate overdose, requiring intensive care.⁷ Adolescents may experiment with medications they find at home, and benzonatate’s seemingly harmless reputation as “just a cough medicine” can give a false sense of safety.

How Overdose Is Treated

There is no antidote for benzonatate. No drug exists that specifically reverses its effects the way naloxone reverses opioid overdose. Treatment is entirely supportive, meaning doctors manage whatever life-threatening problems the drug causes and try to keep the patient alive while the body clears the substance.⁸

In practice, that means:

• Airway management: Because benzonatate can numb the throat and suppress breathing, securing the airway with intubation is often the first priority. The throat-numbing effect makes managing secretions difficult and raises the risk of aspiration.
• Seizure control: Seizures are treated with benzodiazepines, the same class of drugs used for seizures from other causes.
• Cardiac support: Dangerous heart rhythms and cardiac arrest are treated with standard advanced cardiac life support protocols. Sodium bicarbonate may be given to counteract the sodium channel blockade affecting the heart, a strategy borrowed from the treatment of other sodium channel-blocking drug overdoses.
• Continuous monitoring: Because deterioration can happen so rapidly, patients need continuous cardiac and neurological monitoring even if they initially appear stable.⁶

The absence of an antidote is a critical point. With opioid overdoses, bystanders can administer naloxone and potentially reverse the crisis before paramedics arrive. With benzonatate, the only thing a bystander can do is call emergency services and provide CPR if the person’s heart stops. The 14-year-old patient mentioned earlier survived in part because bystanders started CPR immediately.⁵ Without that intervention, the outcome would likely have been different.

Rising Prescriptions, Rising Exposures

Benzonatate has become dramatically more popular over the past two decades. In the United States, its use in office visits more than tripled between 2003 and 2018, and its use in emergency department visits grew even faster, going from about 1.5% to 8% of cough-related visits.⁹ Some of this growth reflects a shift away from codeine-containing cough syrups, which carry their own risks of dependence and respiratory depression. Benzonatate seemed like a safer alternative: non-narcotic, not addictive, effective at suppressing cough.

But more prescriptions inevitably mean more pills in more households, which means more opportunities for accidental ingestion by children and intentional overdose by adults and teenagers. The trend lines for poisoning center calls and adverse event reports have tracked upward alongside the prescription numbers. This is not a case where a drug became more dangerous over time; it is a case where a drug with a known narrow margin of safety became far more widely available, and the predictable consequences followed.

Common Misconceptions About Benzonatate Safety

Because benzonatate is non-narcotic and sold as a simple cough suppressant, many people assume it is essentially harmless. This is probably the single most dangerous misconception about the drug. Patients sometimes take extra capsules when their cough is particularly bothersome, reasoning that “it’s just cough medicine.” They do not realize that taking even a few extra capsules could push them into the toxic range, especially if they are smaller in body weight or have other medications on board that affect sodium channels or the central nervous system.

Another misconception is that overdose symptoms will build slowly enough to seek help. As the FDA data makes clear, collapse can happen within 15 minutes.⁴ By the time someone feels seriously wrong, they may already be seizing or losing consciousness. This is not a drug that gives you a headache and nausea as early warning signs of trouble.

A third misunderstanding involves chewing the capsules. Some patients chew them because they have difficulty swallowing pills, or because they assume breaking the capsule open will make it work faster. What actually happens is that the concentrated anesthetic liquid numbs the mouth and throat, impairing the gag reflex and swallowing ability. Even at a therapeutic dose, this creates aspiration risk. At higher doses, the faster absorption from the broken capsule can accelerate systemic toxicity.

What to Do If You Suspect an Overdose

If you or someone else has taken more benzonatate than prescribed, or if a child has gotten into the medication, call Poison Control (1-800-222-1222 in the US) or 911 immediately. Do not wait for symptoms to appear. Given how quickly this drug can cause cardiac arrest and seizures, the safest assumption is that time matters more than observation. If the person becomes unresponsive and stops breathing normally, begin CPR and continue until emergency medical services arrive.

Emergency physicians managing benzonatate toxicity prioritize stabilizing the heart and stopping seizures, but they need to know what the patient took and roughly how much. If you can bring the pill bottle or count how many capsules are missing, that information helps guide treatment decisions. Since there is no specific antidote, the treatment team is essentially managing a race against the drug’s effects while the body metabolizes and eliminates it.

Safer Use for People Who Need It

None of this means benzonatate should never be prescribed. For many adults with a persistent, disruptive cough, it works well at normal doses and is a reasonable alternative to narcotic cough suppressants. The key is respecting its limits. Swallow the capsules whole without chewing or crushing. Take only the prescribed dose and do not double up if you miss one. Store it where children cannot reach it, and dispose of unused capsules rather than letting them sit in a medicine cabinet indefinitely. If the prescribed dose is not controlling your cough, talk to your doctor about alternatives rather than taking more on your own.

People who take other medications that affect sodium channels or the central nervous system should make sure their prescriber knows their full medication list. Interactions that further depress the nervous system or slow cardiac conduction could lower the threshold for toxicity even at normal benzonatate doses. The same caution applies to people with significant liver or kidney impairment, since changes in drug metabolism could alter how quickly benzonatate is processed and cleared.